United States Government Publishing Office publisher pbl distributor dst United States Congress Senate author aut Government Organization text government publication eng BILLS To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.;Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act;Stop STALLING Act;S. 1095 (IS) Bills and Statutes 119_cong_bills legislative 2025-04-03 U.S. Government Publishing Office 2025-03-24 monographic deposited born digital 7 p. Y 1.6: Y 1.4/1: P0b002ee1d1714eb9 https://www.govinfo.gov/app/details/BILLS-119s1095is S. 1095 021-610-00252-9 000501532 000325576 Congressional bills Senate bills f:s1095_is.txt https://www.govinfo.gov/app/details/BILLS-119s1095is https://www.govinfo.gov/content/pkg/BILLS-119s1095is/html/BILLS-119s1095is.htm https://www.govinfo.gov/content/pkg/BILLS-119s1095is/pdf/BILLS-119s1095is.pdf https://www.govinfo.gov/content/pkg/BILLS-119s1095is/xml/BILLS-119s1095is.xml fdlp DGPO 2025-04-03 2025-04-03 BILLS-119s1095is machine generated eng Amy Klobuchar United States Senate sponsor spn United States Congress Member Chuck Grassley United States Senate cosponsor United States Congress Member Richard J. Durbin United States Senate cosponsor United States Congress Member Richard Blumenthal United States Senate cosponsor United States Congress Member Ted Cruz United States Senate cosponsor United States Congress Member Peter Welch United States Senate cosponsor United States Congress Member Cory A. Booker United States Senate cosponsor United States Congress Member United States Congress Senate Committee on the Judiciary associated name asn Title 5 Section 706(2)(A) 5 U.S.C. 706(2)(A) Title 15 Section 12 Title 15 Section 26 Title 15 Section 45 Title 15 Section 45(a)(1) Title 15 Section 53(b) 15 U.S.C. 12 15 U.S.C. 26 15 U.S.C. 45 15 U.S.C. 45(a)(1) 15 U.S.C. 53(b) Title 21 Section 355 Title 21 Section 355(q) 21 U.S.C. 355 21 U.S.C. 355(q) Title 42 Section 262(k) 42 U.S.C. 262(k) s BILLS-119s1095is 119 1 SENATE SENATE 1095 is is Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act Stop STALLING Act To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Ms. Klobuchar (for herself, Mr. Grassley, Mr. Durbin, Mr. Blumenthal, Mr. Cruz, Mr. Welch, and Mr. Booker) introduced the following bill; which was read twice and referred to the Committee on the Judiciary Committee on the Judiciary Judiciary Ms. Klobuchar Amy Klobuchar Klobuchar, Amy Mr. Grassley Chuck Grassley Grassley, Chuck Mr. Durbin Richard J. Durbin Durbin, Richard J. Mr. Richard Durbin Mr. Blumenthal Richard Blumenthal Blumenthal, Richard Mr. Cruz Ted Cruz Cruz, Ted Mr. Welch Peter Welch Welch, Peter Mr. Booker Cory A. Booker Booker, Cory A. Mr. Cory Booker false false